Showing results 1 to 15 of 15
Issue Date | Title | Author(s) |
---|---|---|
2021-07-27 | A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA | Kwak, Gijung; Kim, Hyosuk; Park, Jooho; Kim, Eun Hye; Jang, Hochung; Han, Geonhee; Wang, Sun Young; Yang, Yoosoo; Kwon, Ick Chan; Kim, Sun Hwa |
2017-08 | Bubbled RNA-Based Cargo for Boosting RNA Interference | Kim, Hyejin; Jeong, Jaepil; Kim, Dajeong; Kwak, Gijung; Kim, Sun Hwa; Lee, Jong Bum |
2018-11 | Development of Biocompatible HA Hydrogels Embedded with a New Synthetic Peptide Promoting Cellular Migration for Advanced Wound Care Management | Wang, Sun Young; Kim, Hyosuk; Kwak, Gijung; Yoon, Hong Yeol; Jo, Sung Duk; Lee, Ji Eun; Cho, Daeho; Kwon, Ick Chan; Kim, Sun Hwa |
2020-02 | Development of microRNA-21 mimic nanocarriers for the treatment of cutaneous wounds | Wang, Sun Young; Kim, Hyosuk; Kwak, Gijung; Jo, Sung Duk; Cho, Daeho; Yang, Yoosoo; Kwon, Ick Chan; Jeong, Ji Hoon; Kim, Sun Hwa |
2019-10 | Exosome-Guided Phenotypic Switch of M1 to M2 Macrophages for Cutaneous Wound Healing | Kim, Hyosuk; Wang, Sun Young; Kwak, Gijung; Yang, Yoosoo; Kwon, Ick Chan; Kim, Sun Hwa |
2021-01 | Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics | Kim, Hyosuk; Kim, Eun Hye; Kwak, Gijung; Chi, Sung-Gil; Kim, Sun Hwa; Yang, Yoosoo |
2017-12 | Harnessing designed nanoparticles: Current strategies and future perspectives in cancer immunotherapy | Jo, Sung Duk; Nam, Gi-Hoon; Kwak, Gijung; Yang, Yoosoo; Kwon, Ick Chan |
2018-04 | Implication of multivalent aptamers in DNA and DNA-RNA hybrid structures for efficient drug delivery in vitro and in vivo | Kang, Yoon Young; Song, Jihyeon; Jung, Hee Sun; Kwak, Gijung; Yu, Gyeonghui; Ahn, Joong-Hoon; Kim, Sun Hwa; Mok, Hyejung |
2020-04 | Necroptosis-Inducible Polymeric Nanobubbles for Enhanced Cancer Sonoimmunotherapy | Um, Wooram; Ko, Hyewon; You, Dong Gil; Lim, Seungho; Kwak, Gijung; Shim, Man Kyu; Yang, Suah; Lee, Jeongjin; Song, Yeari; Kim, Kwangmeyung; Park, Jae Hyung |
2022-05 | PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs | Kim, Eun Hye; Lee, Jongwon; Kwak, Gijung; Jang, Hochung; Kim, Hyosuk; Cho, Haeun; Jang, Yeongji; Choi, Jiwoong; Chi, Sung Gil; Kim, Kwangmeyung; Kwon, Ick Chan; Yang, Yoosoo; Kim, Sun Hwa |
2017-06 | Polyethylenimine-Dermatan Sulfate Complex, a Bioactive Biomaterial with Unique Toxicity to CD146-Positive Cancer Cells | Kim, Bieong-Kil; Kim, Dongkyu; Kwak, Gijung; Yhee, Ji Young; Kwon, Ick-Chan; Kim, Sun Hwa; Yeo, Yoon |
2017-10 | Programmed Cell Death Protein Ligand-1 Silencing with Polyethylenimine-Dermatan Sulfate Complex for Dual Inhibition of Melanoma Growth | Kwak, Gijung; Kirn, Dongkyu; Nam, Gi-hoon; Wang, Sun Young; Kim, In-San; Kim, Sun Hwa; Kwon, Ick-Chan; Yeo, Yoon |
2022-04 | Sustained Exosome-Guided Macrophage Polarization Using Hydrolytically Degradable PEG Hydrogels for Cutaneous Wound Healing: Identification of Key Proteins and MiRNAs, and Sustained Release Formulation | Kwak, Gijung; Cheng, Jing; Kim, Hyosuk; Song, Sukyung; Lee, Su Jin; Yang, Yoosoo; Jeong, Ji Hoon; Lee, Ji Eun; Messersmith, Phillip B.; Kim, Sun Hwa |
2017-12-10 | Synergistic antitumor effects of combination treatment with metronomic doxorubicin and VEGF-targeting RNAi nanoparticles | Kwak, Gijung; Jo, Sung Duk; Kim, Dongkyu; Kim, Hyosuk; Kim, Myung Goo; Kim, Kwangmeyung; Kwon, Ick Chan; Kim, Sun Hwa |
2019-08 | Theranostic designs of biomaterials for precision medicine in cancer therapy | Kim, Hyosuk; Kwak, Gijung; Kim, Kwangmeyung; Yoon, Hong Yeol; Kwon, Ick Chan |